Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

PaperCitations, authors & open-access status

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 286 citations, 2015 year and hybrid oa status.

286
Citations
2015
Year
hybrid
OA Status

Related on ScholarIQ

Anatole Besarab
Author
Nephrology Dialysis Transplantation
Journal
Erythropoietin and Anemia Treatment
Topic
Erythropoietin and Anemia Treatment
Topic
Cancer, Hypoxia, and Metabolism
Topic
Dialysis and Renal Disease Management
Topic
470M+ articles · free account